Search results for: 'd329f chloroform d 10 0.05 ts'

13C, 15N, D fMLF

CCND10073P10
3 - 6 weeks

• 10 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: ¹³C, ¹⁵N, D
• Crystallized

13C, 15N, D Microcrystalline Ubiquitin

CCND10063P10
3 - 6 weeks

• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline SH3

CCND10053P10
3 - 6 weeks

• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Ubiquitin in Solution

CCND10064P10
3 - 6 weeks

• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline GB1

CCND10033P10
3 - 6 weeks

• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D SH3 in Solution

CCND10054P10
3 - 6 weeks

• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D MBP in Solution

CCND10044P10
3 - 6 weeks

• 10 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D GB1 in Solution

CCND10034P10
3 - 6 weeks

• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline SH3

CCND10053P20
3 - 6 weeks

• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline SH3

CCND10053P5
3 - 6 weeks

• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D fMLF

CCND10073P20
3 - 6 weeks

• 20 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: ¹³C, ¹⁵N, D
• Crystallized

13C, 15N, D fMLF

CCND10073P5
3 - 6 weeks

• 5 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: ¹³C, ¹⁵N, D
• Crystallized

13C, 15N, D fMLF

CCND10073P50
3 - 6 weeks

• 50 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: ¹³C, ¹⁵N, D
• Crystallized

13C, 15N, D Microcrystalline Ubiquitin

CCND10063P20
3 - 6 weeks

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline Ubiquitin

CCND10063P5
3 - 6 weeks

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Ubiquitin in 3 mm NMR Tube

CCND100613P
3 - 6 weeks

• Full Length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

13C, 15N, D Ubiquitin in 5 mm NMR Tube

CCND100615P
3 - 6 weeks

• Full Length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0, H₂O/D₂O: 90/10

13C, 15N, D Microcrystalline GB1

CCND10033P20
3 - 6 weeks

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline GB1

CCND10033P5
3 - 6 weeks

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Ubiquitin in Solution

CCND10064P20
3 - 6 weeks

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Ubiquitin in Solution

CCND10064P5
3 - 6 weeks

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Calbindin in 5 mm NMR Tube

CCND100115P
3 - 6 weeks

• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded (Ca and Ln loaded also available on request)
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N, D
• Concentration: 1 mM
• H₂O/D₂O: 90/10, pH: 6.0
• Protein supplied in a 3 mm NMR tube sealed under Argon

13C, 15N, D SH3 in Solution

CCND10054P20
3 - 6 weeks

• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D SH3 in Solution

CCND10054P5
3 - 6 weeks

• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 k Da
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D MBP in Solution

CCND10044P20
3 - 6 weeks

• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D MBP in Solution

CCND10044P5
3 - 6 weeks

• 5 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D GB1 in Solution

CCND10034P20
3 - 6 weeks

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D GB1 in Solution

CCND10034P5
3 - 6 weeks

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

Isogro-13C,15N,D

CCDN540P1

$620.00

2 - 4 weeks

• 1 g
• ¹³C, ¹⁵N, D labeled
• Powder Growth Media

Glycine-13C2,α3-D,15N

CCDN4009P
2 - 4 weeks

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

13C, 15N, D SH3 in 1.3mm Bruker rotor

CCND100521P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D SH3 in 3.2mm Bruker rotor

CCND100523P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

L-Asparagine-13C4,β3-D,15N2

CCDN4004P
2 - 4 weeks

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

L-Cysteine-13C3,β3-D,15N

CCDN4006P
2 - 4 weeks

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

L-Histidine-13C6,β3-D,15N3

CCDN4010P
2 - 4 weeks

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

L-Serine-13C3,β2-D,15N

CCDN4032P
2 - 4 weeks

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

Algal Amino Acids Mixture-13C, 15N, D (16 Amino Acids)

CCDN070P1

$2,090.00

2 - 4 weeks

• 1 g
• 98% ¹³C, 98% ¹⁵N, 98% D
• Deficient in glutamine, asparagine, cysteine, and tryptophan.

13C, 15N, D SH3 in 3mm NMR Tube

CCND100513P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0
• Stable for more than 2 years at 4°C

13C, 15N, D SH3 in 5mm NMR Tube

CCND100515P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D
• Protein conc.: 1 mM, 50 mM Phosphate, pH 7.0
• Stable for more than 2 years at 4°C

13C, 15N, D GB1 in 3.2 mm Bruker rotor

CCND100323P
3 - 6 weeks

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

L-Alanine-β-13CHD2,α-D,15N

CCDN4001P
2 - 4 weeks

L-Aspartic Acid-13C4,β2-D,15N

CCDN4005P
2 - 4 weeks

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

13C, 15N, D MBP in 3 mm NMR Tube

CCND100413P
3 - 6 weeks

• Maltose Binding Protein (Recombinant MBP)
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Protein conc.: 1 mM
• Labeling: ¹³C, ¹⁵N, D
• 20 mM Phosphate, pH: 7.2, Maltotriose: 3 mM, NaN₃: 3 mM, Pefabloc: 50 µM

13C, 15N, D MBP in 5 mm NMR Tube

CCND100415P
3 - 6 weeks

• Maltose Binding Protein (Recombinant MBP)
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Protein conc.: 1 mM
• Labeling: ¹³C, ¹⁵N, D
• 20 mM Phosphate, pH: 7.2, Maltotriose: 3 mM, NaN₃: 3 mM, Pefabloc: 50 µM

Cell-Free Amino Acid mixture - 13C, 15N, D

CCND071P1
stock

• Mixture of 20 Amino Acids, ¹³C, ¹⁵N, D
• Packaging: 1 mL

L-Isoleucine-δ-13CH3,D7,15N

CCDN4014P001
2 - 4 weeks

10 mg

L-Isoleucine-γ2,δ-(13CH3)2,D4,15N

CCDN4013P001
2 - 4 weeks

10 mg

L-Isoleucine-γ-13CH3,D7,15N

CCDN4015P001
2 - 4 weeks

10 mg

L-Leucine-δ2-13CH3,D7,15N

CCDN4018P001
2 - 4 weeks

10 mg

L-Leucine-δ1-13CH3,D7,15N

CCDN4019P001
2 - 4 weeks

10 mg

L-Methionine-ε-13CH3,D5,15N

CCDN4025P001
2 - 4 weeks

10 mg

L-Phenylalanine-ζ-13CH,D7,15N

CCDN4028P001
2 - 4 weeks

10 mg

L-Phenylalanine-ε-13CH,D6,15N

CCDN4030P001
2 - 4 weeks

10 mg

L-Tyrosine-ε-13CH,D5,15N

CCDN4037P001
2 - 4 weeks

10 mg

L-Valine-γ1-13CH3,D5,15N

CCDN4041P001
2 - 4 weeks

10 mg

L-Valine-γ2-13CH3,D5,15N

CCDN4042P001
2 - 4 weeks

10 mg

Spectra 9-DCN

CCDN3780L
2 - 4 weeks

98%¹³C, 98%¹⁵N, 98% D

L-Histidine-13C6, 15N3, α,β,β,2,5-d5

CCDN1200P01
2 - 4 weeks

• 100 mg• 99% ¹³C, 98% D, 98% ¹⁵N
• 95% CP

L-Phenylalanine-13C9, 15N, α,β,β,2,3,4,5,6-d8

CCDN2200P01
2 - 4 weeks

• 100 mg• 99% ¹³C, 98% D, 98% ¹⁵N
• 95% CP

L-Valine-13C5,15N,2,3,4,4,4-d5-(4-methyl-d3)

CCDN5000P01
2 - 4 weeks

• 100 mg• 99% ¹³C, 98% D, 98% ¹⁵N
• 95% CP

L-Cysteine-13C3,15N,2,3,3-d3

CCDN500P01
2 - 4 weeks

• 100 mg• 98% ¹³C, 98% D, 98% ¹⁵N
• 95% CP

L-Alanine-13C3, 15N, 2,3,3,3-d4

CCDN55P01
2 - 4 weeks

• 100 mg • 99% ¹³C, 98% D, 98% ¹⁵N
• 95% CP

Celtone-CDN

CCDN530P
2 - 4 weeks

• Powder Only
• 98% ¹³C, 98% ¹⁵N, 98% D

Celtone-CDN

CCDN531L
2 - 4 weeks

• Complete Media
• 98% ¹³C, 98% ¹⁵N, 98% D

L-Threonine-13C4,δ,δ-D2,15N

CCDN4033P
2 - 4 weeks

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

L-Tyrosine-13C9, 15N, -d7

CCDN4200P
2 - 4 weeks

99% ¹³C, 98% ¹⁵N, 98% D

L-Glutamic Acid-13C5, 15N, -d9

CCDN900P
2 - 4 weeks

• 98% ¹³C, 98% D, 98% ¹⁵N
• 95% CP

Glycine-13C2, 15N, 2,2-d2

CCDN1090P01
2 - 4 weeks

H₂¹⁵N¹³CD₂¹³CO₂H

L-Isoleucine-13C6, 15N, 2,3,4,4,5,5,5-d7,3-methyl-d3

CCDN1300P01
2 - 4 weeks

¹³CD₃¹³CD₂¹³CD(¹³CD₃)¹³CD(¹⁵NH₂)CO₂H

L-Methionine-13C5, 15N, 2,3,3,4,4-d5-(methyl-d3)

CCDN2000P01
2 - 4 weeks

¹³CD₃S¹³CD₂¹³CD₂¹³CD(¹⁵NH₂)¹³CO₂H

L-Proline-13C5, 15N, 2,3,3,4,4,5,5-d7

CCDN2500P01
2 - 4 weeks

¹³C₄D₇¹⁵NH¹³CO₂H

L-Serine-13C3,15N,2,3,3-d3

CCDN3000P01
2 - 4 weeks

HO¹³CD₂¹³CD(¹⁵NH₂)¹³CO₂H

L-Tryptophan-13C11,15N2,α,β,β,2,4,5,6,7-d8

CCDN4050P01
2 - 4 weeks

• 100 mg• 97% ¹³C
• 98% CP

L-Tyrosine-c’,α,β,γ,ε1,ε2-13C6, β2,δ-D3,15N

CCDN4036P
2 - 4 weeks

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

L-Phenylalanine-c’,α,β,γ,ζ-13C5,β2,δ,ε1,ε2-D5,15N

CCDN4026P
2 - 4 weeks

• Original SAIL amino acid
• Preservation of through-bond connectivity
• Reduction of spin diffusion
• Removal of ²J_HH couplings
• Reduction of number of protons 50%

Search results for: 'd329f chloroform d 10 0.05 ts'

Shop

Experience

Useful Links

Corporate